2m 2m 2m 2m 2m 2m 2m
Galectin (GALT)
NASDAQ
$3.65-$0.03 (-0.82%)
Price as of Aug 21, 2026 7:47 PM EDT- $371.1MMarket Cap
- -10.24%1-Year Change
- BiotechnologyIndustry
Galectin (GALT)
$3.65-$0.03 (-0.82%)
GALT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.68 | ||
Change | +$0.11 (+3.08%) | ||
Open | $3.62 | ||
High | $3.74 | ||
Low | $3.59 | ||
Previous Close | $3.57 | ||
Volume | 174,932 | ||
30-Day Average Volume | 369,513 | ||
1-Week Change | 6.98% | ||
1-Month Change | -4.29% | ||
1-Year Change | -10.24% | ||
3-Year Change | 127.16% | ||
5-Year Change | 9.20% | ||
Fundamentals | |||
Shares Outstanding | 100.8M | ||
Total Assets | $14.8M | ||
Market Cap | $371.1M | ||
Enterprise Value | $357.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$9.1M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$9.1M | ||
EBITDA | -$9.1M | ||
Net Working Capital | -$137.0M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -3 | ||
P/E | -26 | ||
PEG | 0 | ||
Price/Free Cash Flow | -152 | ||
Price/Operating Cash Flow | -152 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 03/23/2012 | ||
Earnings & Revenue